We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


TAU Protein Aggregation Assay Relevance to Alzheimer’s Disease and Tauopathies Research

While Alzheimer’s disease remains a largely unmet medical condition, the role of Tau protein in its pathogenesis and expansion becomes increasingly prevalent and investigated. New technologies, such as Homogenous Time Resolved Fluorescence (HTRF) have been developed alongside this and could hold the key to improving our understanding.

Download this application note to find out how HTRF technology can be used to:

  • Determine how Tau leads to neuronal disorders
  • Monitor uptake of Tau aggregates
  • Develop inhibitors to Tau aggregation